Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
June 28, 2018

First artificial iris provides a novel method for treating iris defects

CustomFlex, by HumanOptics AG, is the first stand-alone prosthetic iris in the US, following its approval by the FDA.

By GBI Research

CustomFlex, by HumanOptics AG, is the first stand-alone prosthetic iris in the US, following its approval by the FDA.

The surgically implanted device will be available for adults and children whose iris is completely missing or damaged whether due to a congenital condition called aniridia or due to other damage to the eye.

A rare genetic disorder

Congenital aniridia is a rare genetic disorder in which the iris is completely or partially absent.

It affects approximately 1 in 50,000–100,000 people in the US.

The iris controls the amount of light entering the eye, and those with aniridia have sensitivity to light and other severe vision problems.

Reduces sensitivity to bright light and glare

In clinical trials, more than 70% of patients reported significant decreases in light sensitivity and glare as well as an improvement in health-related quality of life following the procedure, and 94% of patients were satisfied with the artificial iris’s appearance.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

The CustomFlex Artificial Iris provides a novel method for treating iris defects that reduces sensitivity to bright light and glare.

It also improves the cosmetic appearance of the eye in patients with aniridia, offering patients an opportunity to improve how they see and how they are seen.

Related Companies

Related Report
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU